Ginger, Curcumin, and Cancer: Scientific Overview
Important Disclaimer: The data presented are PRECLINICAL (in vitro and animal studies). Ginger and turmeric are NOT cancer treatments. Never replace conventional treatment. Always consult your oncologist.
What Preclinical Studies Show
Curcumin and gingerol are among the most studied natural compounds in cancer research, with over 12,000 publications on PubMed.
Three Documented Mechanisms (in vitro)
| Mechanism | Compound | Action | References |
|---|---|---|---|
| NF-κB Inhibition | Curcumin + Gingerol | Blocks tumor cell survival | Aggarwal et al., 2004 |
| Apoptosis Induction | Curcumin | Caspase 3/9 activation | Ravindran et al., 2009 |
| Angiogenesis Inhibition | Curcumin | ↓ VEGF (tumor vascularization) | Arbiser et al., 1998 |
Why NF-κB is a Cancer Target
NF-κB is constitutively activated in many cancers (colorectal, breast, prostate, pancreas). Its inhibition is an active research strategy in oncology. Curcumin and gingerol inhibit NF-κB through complementary pathways (IKK-β and IκBα).
Important Limitations
- In vitro ≠ in vivo — cell-based results do not always translate to humans
- Bioavailability — in vitro concentrations are often unrealistic for oral intake
- Clinical trials — Phase II ongoing, preliminary results
- Complementary only — never as a replacement for standard treatment
The Sugar Factor in Oncology
NF-κB is activated in many cancers. Sugar activates NF-κB (Mauro, 2011). Reducing sugar is consistent with oncology research — even if a shot alone is not a treatment.
INTI — organic ginger + turmeric + black pepper, 1.19g sugar/100ml. Complementary, not curative. Consult your doctor.